Priority Date: 14.06.06 (US 20060813903P)

Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity

  • Application ID: EP14166617
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 14.06.2006 - Priority Date (US 20060813903P)
  • 24.12.2014 - Publication A1 (EP2815764)